Kemper Corporation (NYSE:KMPR) shares advanced 3.28% in last trading session and ended the day at $29.27. KMPR has a return on assets of 1.10%. Kemper Corporation (NYSE:KMPR) quarterly performance is -22.20%.
Kemper Corporation (NYSE:KMPR) said that, it will continue competing in both cross country and track and field for the Bears, which are both coached by the veteran mentor Putnam.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) ended the last trading day at $0.40. Company weekly volatility is calculated as 8.16% and price to cash ratio as 1.38. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) showed a weekly performance of -9.36%.
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) will trade ex-dividend, for its quarterly dividend of $0.6562, payable on 4/1/16. As a percentage of PPHMP’s recent share price of $16.92, this dividend works out to approximately 3.88%, so look for shares of PPHMP to trade 3.88% lower – all else being equal – when PPHMP shares open for trading on 3/16/16.
On 28 March, NVIDIA Corporation (NASDAQ:NVDA) shares increased 1.02% and was closed at $34.83. NVDA EPS growth in last 5 year was 20.20%. NVIDIA Corporation (NASDAQ:NVDA) year to date (YTD) performance is 6.06%.
On 25 March, NVIDIA Corporation (NASDAQ:NVDA) said that. Its upcoming Pascal architecture will not be significantly better at Async Compute than its predecessor (Maxwell).
Amgen Inc. (NASDAQ:AMGN) shares moved down -0.58% in last trading session and ended the day at $148.37. AMGN Gross Margin is 80.50% and its has a return on assets of 9.80%. Amgen Inc. (NASDAQ:AMGN) quarterly performance is -8.18%.
Amgen Inc. (NASDAQ:AMGN) announced that it will present 19 abstracts related to its cardiovascular portfolio, including new detailed data evaluating Repatha® (evolocumab) in patients with high cholesterol who cannot tolerate statins, at the American College of Cardiology’s 65th Annual Scientific Session (ACC.16) in Chicago, April 2-4, 2016.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) caters to the Healthcare space. Its and weekly performance is 3.00%. On the last day of trading company shares ended up at $0.24. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) distance from 50-day simple moving average (SMA50) is -121.50%.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) provides an overview of the Synta Pharmaceuticals Corp. ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Synta Pharmaceuticals Corp., complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Leave a Reply